BG

Bindu Girisha

Active Director Additional Director DIN 07926680
DIN 07926680 First appointment Mar 2025 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Bindu Girisha

Data last updated:

Bindu Girisha is an Additional Director at Curabit Life Sciences Private Limited (since 2025). The company operates in Life Sciences. Curabit Life Sciences Private Limited reported revenue of ₹95 Lakh (FY 2025).

DIN 07926680
Primary Designation Additional Director
Industry Life Sciences
First Appointment 20 Mar 2025
Oldest Company Age 5 yrs
Largest company Curabit Life Sciences Private Limited · ₹95 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director20 Mar 20252021₹95 Lakh (FY 2025)Active

Board colleagues of Bindu Girisha

Directorship timeline

Open interactive timeline →
Curabit Life Sciences Private Limited
Premium access

Shareholding and investment profile for Bindu Girisha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bindu Girisha

Bindu Girisha currently holds 1 directorship: Curabit Life Sciences Private Limited (Additional Director, since 20 Mar 2025, revenue ₹95 Lakh (FY 2025)).

Bindu Girisha was first appointed on 20 Mar 2025 as Additional Director at Curabit Life Sciences Private Limited.

The current boards of Bindu Girisha's companies include Girisha Lakkappala Sivanandappa (Curabit Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available